Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Jörn Bullerdiek

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Chemicals & Drugs

Anatomy

Living Beings

Dogs

Concepts & Ideas

Molecular Sequence Data

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
87
Bartnitzke, S
42
Rogalla, Piere
40
Kazmierczak, B
34
Nolte, Ingo
29
Belge, Gazanfer
28
Murua Escobar, Hugo
26
Wanschura, S
21
Bonk, Ulrich
20
Van Den Berghe, Herman
17
Thode, B
17
Van De Ven, Wim
16
Winkler, Susanne
15
Schoenmakers, Eric
14
Reimann-Berg, Nicola
14
Dal Cin, Paola

Sign-in to see all Coauthors

Publications

TOP 3
Fehr André; Meyer Anke; Heidorn Klaus; Röser Kerstin; Löning Thomas; Bullerdiek Jörn
A link between the expression of the stem cell marker HMGA2, grading, and the fusion CRTC1-MAML2 in mucoepidermoid carcinoma.
Verdorfer Irmgard; Fehr Andre; Bullerdiek Jörn; Scholz Nina; Brunner Andrea; Krugmann Jens; Hager Martina; Haufe Heike; Mikuz Gregor; Scholtz Arne
Chromosomal imbalances, 11q21 rearrangement and MECT1-MAML2 fusion transcript in mucoepidermoid carcinomas of the salivary gland.
Sterenczak Katharina A; Willenbrock Saskia; Barann Matthias; Klemke Markus; Soller Jan T; Eberle Nina; Nolte Ingo; Bullerdiek Jörn; Murua Escobar Hugo
Cloning, characterisation, and comparative quantitative expression analyses of receptor for advanced glycation end products (RAGE) transcript forms.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Jörn Bullerdiek (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Fehr André; Meyer Anke; Heidorn Klaus; Röser Kerstin; Löning Thomas; Bullerdiek Jörn
A link between the expression of the stem cell marker HMGA2, grading, and the fusion CRTC1-MAML2 in mucoepidermoid carcinoma.
Genes, chromosomes & cancer 2009;48(9):777-85.
2009: Verdorfer Irmgard; Fehr Andre; Bullerdiek Jörn; Scholz Nina; Brunner Andrea; Krugmann Jens; Hager Martina; Haufe Heike; Mikuz Gregor; Scholtz Arne
Chromosomal imbalances, 11q21 rearrangement and MECT1-MAML2 fusion transcript in mucoepidermoid carcinomas of the salivary gland.
Oncology reports 2009;22(2):305-11.
2009: Sterenczak Katharina A; Willenbrock Saskia; Barann Matthias; Klemke Markus; Soller Jan T; Eberle Nina; Nolte Ingo; Bullerdiek Jörn; Murua Escobar Hugo
Cloning, characterisation, and comparative quantitative expression analyses of receptor for advanced glycation end products (RAGE) transcript forms.
Gene 2009;434(1-2):35-42.
2009: Richter Andreas; Hauschild Gregor; Murua Escobar Hugo; Nolte Ingo; Bullerdiek Jörn
Application of high-mobility-group-A proteins increases the proliferative activity of chondrocytes in vitro.
Tissue engineering. Part A 2009;15(3):473-7.
2009: Petersen Svea; Soller Jan T; Wagner Siegfried; Richter Andreas; Bullerdiek Jörn; Nolte Ingo; Barcikowski Stephan; Murua Escobar Hugo
Co-transfection of plasmid DNA and laser-generated gold nanoparticles does not disturb the bioactivity of GFP-HMGB1 fusion protein.
Journal of nanobiotechnology 2009;7():6.
2008: Winter N; Neumann A; Bullerdiek J
Cell-free DNA in amniotic fluid remains to be attached to HMGA2-implications for noninvasive prenatal diagnosis.
Prenatal diagnosis 2008;28(12):1126-30.
2008: von Ahsen Inga; Nimzyk Rolf; Klemke Markus; Bullerdiek Jörn
A microRNA encoded in a highly conserved part of the mammalian HMGA2 gene.
Cancer genetics and cytogenetics 2008;187(1):43-4.
2008: Meyer Anke; Staratschek-Jox Andrea; Springwald Anette; Wenk Heiner; Wolf Jurgen; Wickenhauser Claudia; Bullerdiek Jörn
Non-Hodgkin lymphoma expressing high levels of the danger-signalling protein HMGB1.
Leukemia & lymphoma 2008;49(6):1184-9.
2008: Reimann-Berg Nicola; Murua Escobar Hugo; Nolte Ingo; Bullerdiek Jörn
Testicular tumor in an XXY dog.
Cancer genetics and cytogenetics 2008;183(2):114-6.
2008: Fehr André; Röser Kerstin; Heidorn Klaus; Hallas Cora; Löning Thomas; Bullerdiek Jörn
A new type of MAML2 fusion in mucoepidermoid carcinoma.
Genes, chromosomes & cancer 2008;47(3):203-6.
2008: Fehr André; Röser Kerstin; Belge Gazanfer; Löning Thomas; Bullerdiek Jörn
A closer look at Warthin tumors and the t(11;19).
Cancer genetics and cytogenetics 2008;180(2):135-9.
2008: Belge Gazanfer; Meyer Anke; Klemke Markus; Burchardt Käte; Stern Corinna; Wosniok Werner; Loeschke Siegfried; Bullerdiek Jörn
Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias.
Genes, chromosomes & cancer 2008;47(1):56-63.
2008: Fork Melani A M; Murua Escobar Hugo; Soller Jan T; Sterenczak Katharina A; Willenbrock Saskia; Winkler Susanne; Dorsch Martina; Reimann-Berg Nicola; Hedrich Hans J; Bullerdiek Jörn; Nolte Ingo
Establishing an in vivo model of canine prostate carcinoma using the new cell line CT1258.
BMC cancer 2008;8():240.
2007: Drieschner Norbert; Kerschling Svenja; Soller Jan T; Rippe Volkhard; Belge Gazanfer; Bullerdiek Jörn; Nimzyk Rolf
A domain of the thyroid adenoma associated gene (THADA) conserved in vertebrates becomes destroyed by chromosomal rearrangements observed in thyroid adenomas.
Gene 2007;403(1-2):110-7.
2007: Meyer B; Krisponeit D; Junghanss C; Murua Escobar H; Bullerdiek J
Quantitative expression analysis in peripheral blood of patients with chronic myeloid leukaemia: correlation between HMGA2 expression and white blood cell count.
Leukemia & lymphoma 2007;48(10):2008-13.
2007: Winkler Susanne; Murua Escobar Hugo; Meyer Britta; Simon Daniela; Eberle Nina; Baumgartner Wolfgang; Loeschke Siegfried; Nolte Ingo; Bullerdiek Jörn
HMGA2 expression in a canine model of prostate cancer.
Cancer genetics and cytogenetics 2007;177(2):98-102.
2007: Meyer Britta; Loeschke Siegfried; Schultze Anke; Weigel Thomas; Sandkamp Martin; Goldmann Torsten; Vollmer Ekkehard; Bullerdiek Jörn
HMGA2 overexpression in non-small cell lung cancer.
Molecular carcinogenesis 2007;46(7):503-11.
2007: Soller Jan T; Murua-Escobar Hugo; Willenbrock Saskia; Janssen Miriam; Eberle Nina; Bullerdiek Jörn; Nolte Ingo
Comparison of the human and canine cytokines IL-1(alpha/beta) and TNF-alpha to orthologous other mammalians.
The Journal of heredity 2007;98(5):485-90.
2007: Jensen J; Simon D; Murua Escobar H; Soller J T; Bullerdiek J; Beelitz P; Pfister K; Nolte I
Anaplasma phagocytophilum in dogs in Germany.
Zoonoses and public health 2007;54(2):94-101.
2006: Drieschner N; Belge G; Rippe V; Meiboom M; Loeschke S; Bullerdiek J
Evidence for a 3p25 breakpoint hot spot region in thyroid tumors of follicular origin.
Thyroid : official journal of the American Thyroid Association 2006;16(11):1091-6.
2006: Soller Jan Thies; Murua Escobar Hugo; Janssen Miriam; Fork Melani; Bullerdiek Jörn; Nolte Ingo
Cytokine genes single nucleotide polymorphism (SNP) screening analyses in canine malignant histiocytosis.
Anticancer research 2006;26(5A):3417-20.
2006: von Ahsen Inga; Rogalla Piere; Bullerdiek Jörn
Germ line mutations of the HMGA2 gene are rare among the general population.
Anticancer research 2006;26(5A):3289-91.
2006: Winkler Susanne; Reimann-Berg Nicola; Murua Escobar Hugo; Loeschke Siegfried; Eberle Nina; Höinghaus Ruth; Nolte Ingo; Bullerdiek Jörn
Polysomy 13 in a canine prostate carcinoma underlining its significance in the development of prostate cancer.
Cancer genetics and cytogenetics 2006;169(2):154-8.
2006: Murua Escobar Hugo; Soller Jan T; Sterenczak Katharina A; Sperveslage Jan D; Schlueter Claudia; Burchardt Birgit; Eberle Nina; Fork Melanie; Nimzyk Rolf; Winkler Susanne; Nolte Ingo; Bullerdiek Jörn
Cloning and characterization of the canine receptor for advanced glycation end products.
Gene 2006;369():45-52.
2005: Mohamed Salah Ali; Hanke Thorsten; Schlueter Claudia; Bullerdiek Joern; Sievers Hans-Hinrich
Ubiquitin fusion degradation 1-like gene dysregulation in bicuspid aortic valve.
The Journal of thoracic and cardiovascular surgery 2005;130(6):1531-6.
2005: Winkler Susanne; Murua Escobar Hugo; Reimann-Berg Nicola; Bullerdiek Jörn; Nolte Ingo
Cytogenetic investigations in four canine lymphomas.
Anticancer research 2005;25(6B):3995-8.
2005: von Ahsen Inga; Rogalla Piere; Bullerdiek Jörn
Expression patterns of the LPP-HMGA2 fusion transcript in pulmonary chondroid hamartomas with t(3;12)(q27 approximately 28;q14 approximately 15).
Cancer genetics and cytogenetics 2005;163(1):68-70.
2005: Röser K; Jäkel K T; Bullerdiek J; Löning T
[Significance of molecular-cytogenetic findings in mucoepidermoid carcinoma as an example of salivary gland tumors]
Der Pathologe 2005;26(5):359-66.
2005: Martins Carmo; Fonseca Isabel; Roque Lúcia; Pereira Teresa; Ribeiro Catarina; Bullerdiek Jörn; Soares Jorge
PLAG1 gene alterations in salivary gland pleomorphic adenoma and carcinoma ex-pleomorphic adenoma: a combined study using chromosome banding, in situ hybridization and immunocytochemistry.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005;18(8):1048-55.
2005: Hauke Sven; Leopold Silke; Schlueter Claudia; Flohr Aljoscha M; Murua Escobar Hugo; Rogalla Piere; Bullerdiek Jörn
Extensive expression studies revealed a complex alternative splicing pattern of the HMGA2 gene.
Biochimica et biophysica acta 2005;1729(1):24-31.
2005: Schlueter Claudia; Weber Holger; Meyer Britta; Rogalla Piere; Röser Kerstin; Hauke Sven; Bullerdiek Jörn
Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule.
The American journal of pathology 2005;166(4):1259-63.
2005: Kuechler Alma; Ziegler Monika; Blank Cornelia; Rommel Birgit; Bullerdiek Joern; Ahrens Jochen; Claussen Uwe; Liehr Thomas
A highly complex chromosomal rearrangement between five chromosomes in a healthy female diagnosed in preparation for intracytoplasmatic sperm injection.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2005;53(3):355-7.
2005: Richter A; Murua Escobar H; Günther K; Soller J T; Winkler S; Nolte I; Bullerdiek J
RAS gene hot-spot mutations in canine neoplasias.
The Journal of heredity 2005;96(7):764-5.
2005: Winkler S; Murua Escobar H; Eberle N; Reimann-Berg N; Nolte I; Bullerdiek J
Establishment of a cell line derived from a canine prostate carcinoma with a highly rearranged karyotype.
The Journal of heredity 2005;96(7):782-5.
2005: Murua Escobar H; Soller J T; Richter A; Meyer B; Winkler S; Bullerdiek J; Nolte I
"Best friends" sharing the HMGA1 gene: comparison of the human and canine HMGA1 to orthologous other species.
The Journal of heredity 2005;96(7):777-81.
2005: Schlueter Claudia; Hauke Sven; Loeschke Siegfried; Wenk Heiner Hans; Bullerdiek Jörn
HMGA1 proteins in human atherosclerotic plaques.
Pathology, research and practice 2005;201(2):101-7.
2004: Meyer J; Murua Escobar H; Bartnitzke S; Schelling C; Dolf G; Nolte I; Bullerdiek J
The FAS-activated serine/threonine kinase gene maps to canine chromosome 16.
Animal genetics 2004;35(6):497.
2004: Meyer B; Murua Escobar H; Winkler S; Dolf G; Schelling C; Bullerdiek J; Nolte I
Molecular characterization and mapping of the canine cyclin D1 (CCND1) gene.
Animal genetics 2004;35(5):413.
2004: Murua Escobar Hugo; Günther Kathrin; Richter Andreas; Soller Jan T; Winkler Susanne; Nolte Ingo; Bullerdiek Jörn
Absence of ras-gene hot-spot mutations in canine fibrosarcomas and melanomas.
Anticancer research 2004;24(5A):3027-8.
2004: Richter A; Murua Escobar H; Günther K; Meyer B; Winkler S; Dolf G; Schelling C; Nolte I; Bullerdiek J
The canine NRAS gene maps to CFA 17.
Animal genetics 2004;35(4):355-6.
2004: Murua Escobar H; Meyer J; Winkler S; Schelling C; Dolf G; Nolte I; Bullerdiek J
The protein kinase B, gamma (AKT3) gene maps to canine chromosome 7.
Animal genetics 2004;35(4):354-5.
2004: Winkler S; Murua Escobar H; Günther K; Richter A; Dolf G; Schelling C; Bullerdiek J; Nolte Ingo
The canine KRAS2 gene maps to chromosome 22.
Animal genetics 2004;35(4):350-1.
2004: Meiboom M; Murua Escobar H; Winkler S; Nolte I; Bullerdiek J
Molecular characterization and mapping of the canine KRAB zinc finger gene ZNF331.
Animal genetics 2004;35(3):262-3.
2004: Murua Escobar Hugo; Soller Jan T; Richter Andreas; Meyer Britta; Winkler Susanne; Flohr Aljoscha M; Nolte Ingo; Bullerdiek Jörn
The canine HMGA1.
Gene 2004;330():93-9.
2004: Meyer Britta; Murua Escobar Hugo; Hauke Sven; Richter Andreas; Winkler Susanne; Rogalla Piere; Flohr Aljoscha M; Bullerdiek Jörn; Nolte Ingo
Expression pattern of the HMGB1 gene in sarcomas of the dog.
Anticancer research 2004;24(2B):707-10.
2004: Goldmann Torsten; Flohr Aljoscha M; Murua Escobar Hugo; Gerstmayer Bernhard; Janssen Uwe; Bosio Andreas; Loeschke Siegfried; Vollmer Ekkehard; Bullerdiek Jörn
The HOPE-technique permits Northern blot and microarray analyses in paraffin-embedded tissues.
Pathology, research and practice 2004;200(7-8):511-5.
2003: Borrmann Lars; Schwanbeck Ralf; Heyduk Tomasz; Seebeck Birte; Rogalla Piere; Bullerdiek Jörn; Wisniewski Jacek R
High mobility group A2 protein and its derivatives bind a specific region of the promoter of DNA repair gene ERCC1 and modulate its activity.
Nucleic acids research 2003;31(23):6841-51.
2003: Flohr Aljoscha M; Hackenbeck Thomas; Schlueter Claudia; Rogalla Piere; Bullerdiek Joern
DNase I treatment of cDNA first strands prevents RT-PCR amplification of contaminating DNA sequences.
BioTechniques 2003;35(5):920-2, 924, 926.
2003: Bamberger Ana-Maria; Makrigiannakis Antonis; Röser Kerstin; Radde Jessica; Carstens Tanja; Flohr Aljoscha M; Bamberger Christoph M; Bullerdiek Jörn; Löning Thomas
Expression of the high-mobility group protein HMGI(Y) in human trophoblast: potential role in trophoblast invasion of maternal tissue.
Virchows Archiv : an international journal of pathology 2003;443(5):649-54.
2003: Schlueter Claudia; Hauke Sven; Flohr Aljoscha M; Rogalla Piere; Bullerdiek Jörn
Tissue-specific expression patterns of the RAGE receptor and its soluble forms--a result of regulated alternative splicing?
Biochimica et biophysica acta 2003;1630(1):1-6.
2003: Meiboom Maren; Belge Gazanfer; Bol Silvia; El-Aouni Chiraz; Schoenmakers Eric F; Bullerdiek Jörn
Does conventional cytogenetics detect the real frequency of 19q13 aberrations in benign thyroid lesions? A survey of 38 cases.
Cancer genetics and cytogenetics 2003;146(1):70-2.
2003: Flohr A M; Rogalla P; Bonk U; Puettmann B; Buerger H; Gohla G; Packeisen J; Wosniok W; Loeschke S; Bullerdiek J
High mobility group protein HMGA1 expression in breast cancer reveals a positive correlation with tumour grade.
Histology and histopathology 2003;18(4):999-1004.
2003: Rippe Volkhard; Drieschner Norbert; Meiboom Maren; Murua Escobar Hugo; Bonk Ulrich; Belge Gazanfer; Bullerdiek Jörn
Identification of a gene rearranged by 2p21 aberrations in thyroid adenomas.
Oncogene 2003;22(38):6111-4.
2003: Gross Karen L; Neskey David M; Manchanda Nitasha; Weremowicz Stanislawa; Kleinman Michael S; Nowak Romana A; Ligon Azra H; Rogalla Piere; Drechsler Klaus; Bullerdiek Jörn; Morton Cynthia C
HMGA2 expression in uterine leiomyomata and myometrium: quantitative analysis and tissue culture studies.
Genes, chromosomes & cancer 2003;38(1):68-79.
2003: Becker K; Murua Escobar H; Richter A; Meyer B; Nolte I; Bullerdiek Jörn
The canine HMGA1 gene maps to CFA 23.
Animal genetics 2003;34(1):68-9.
2003: Borrmann Lars; Seebeck B; Rogalla P; Bullerdiek J
Human HMGA2 promoter is coregulated by a polymorphic dinucleotide (TC)-repeat.
Oncogene 2003;22(5):756-60.
2003: Kayser Klaus; Dünnwald Delia; Kazmierczak Bernd; Bullerdiek Jörn; Kaltner Herbert; Zick Yehiel; André Sabine; Gabius Hans-Joachim
Chromosomal aberrations, profiles of expression of growth-related markers including galectins and environmental hazards in relation to the incidence of chondroid pulmonary hamartomas.
Pathology, research and practice 2003;199(9):589-98.
2003: Meiboom M; Murua Escobar H; Pentimalli F; Fusco A; Belge G; Bullerdiek J
A 3.4-kbp transcript of ZNF331 is solely expressed in follicular thyroid adenomas.
Cytogenetic and genome research 2003;101(2):113-7.
2003: Murua Escobar H; Meyer B; Richter A; Becker K; Flohr A M; Bullerdiek J; Nolte I
Molecular characterization of the canine HMGB1.
Cytogenetic and genome research 2003;101(1):33-8.
2002: Vockerodt Martina; Belge Gazanfer; Kube Dieter; Irsch Johannes; Siebert Reiner; Tesch Hans; Diehl Volker; Wolf Jürgen; Bullerdiek Jörn; Staratschek-Jox Andrea
An unbalanced translocation involving chromosome 14 is the probable cause for loss of potentially functional rearranged immunoglobulin heavy chain genes in the Epstein-Barr virus-positive Hodgkin's lymphoma-derived cell line L591.
British journal of haematology 2002;119(3):640-6.
2002: Lemke Inga; Rogalla Piere; Grundmann Felix; Kunze Wolf Peter; Haupt Rolf; Bullerdiek Jörn
Expression of the HMGA2-LPP fusion transcript in only 1 of 61 karyotypically normal pulmonary chondroid hamartomas.
Cancer genetics and cytogenetics 2002;138(2):160-4.
2002: Rogalla Piere; Helbig Roger; Drieschner Norbert; Flohr Aljoscha M; Krohn Maren; Bullerdiek Jörn
Molecular-cytogenetic analysis of fragmentation of chromosome 17 in the breast cancer cell line EFM-19.
Anticancer research 2002;22(4):1987-92.
2002: Hauke Sven; Flohr Aljoscha M; Rogalla Piere; Bullerdiek Jörn
Sequencing of intron 3 of HMGA2 uncovers the existence of a novel exon.
Genes, chromosomes & cancer 2002;34(1):17-23.
2002: Rogalla Piere; Lemke Inga; Bullerdiek Jörn
Absence of HMGIC-LHFP fusion in pulmonary chondroid hamartomas with aberrations involving chromosomal regions 12q13 through 15 and 13q12 through q14.
Cancer genetics and cytogenetics 2002;133(1):90-3.
2002: Röijer Eva; Nordkvist Anders; Ström Anna-Karin; Ryd Walter; Behrendt Margareta; Bullerdiek Jörn; Mark Joachim; Stenman Göran
Translocation, deletion/amplification, and expression of HMGIC and MDM2 in a carcinoma ex pleomorphic adenoma.
The American journal of pathology 2002;160(2):433-40.
2001: Flohr A M; Rogalla P; Meiboom M; Borrmann L; Krohn M; Thode-Halle B; Bullerdiek J
Variation of HMGB1 expression in breast cancer.
Anticancer research 2001;21(6A):3881-5.
2001: Rogalla P; Blank C; Helbig R; Wosniok W; Bullerdiek J
Significant correlation between the breakpoints of rare clonal aberrations in benign solid tumors and the assignment of HMGIY retropseudogenes.
Cancer genetics and cytogenetics 2001;130(1):51-6.
2001: Lemke I; Rogalla P; Bullerdiek J
Large deletion of part of the HMGIC locus accompanying a t(3;12)(q27 approximately q28;q14 approximately q15) in a lipoma.
Cancer genetics and cytogenetics 2001;129(2):161-4.
2001: Borrmann L; Wilkening S; Bullerdiek J
The expression of HMGA genes is regulated by their 3'UTR.
Oncogene 2001;20(33):4537-41.
2001: Bol S; Belge G; Thode B; Bonk U; Bartnitzke S; Bullerdiek J
Cytogenetic tetraclonality in a rare spindle cell variant of an anaplastic carcinoma of the thyroid.
Cancer genetics and cytogenetics 2001;125(2):163-6.
2001: Hauke S; Rippe V; Bullerdiek J
Chromosomal rearrangements leading to abnormal splicing within intron 4 of HMGIC?
Genes, chromosomes & cancer 2001;30(3):302-4.
2001: Staratschek-Jox A; Thomas R K; Zander T; Massoudi N; Kornacker M; Bullerdiek J; Fonatsch C; Diehl V; Wolf J
Loss of heterozygosity in the Hodgkin-Reed Sternberg cell line L1236.
British journal of cancer 2001;84(3):381-7.
2001: Borrmann L; Kim I; Schultheiss D; Rogalla P; Bullerdiek J
Regulation of the expression of HMG1, a co-activator of the estrogen receptor.
Anticancer research 2001;21(1A):301-5.
2001: Piekielko A; Drung A; Rogalla P; Schwanbeck R; Heyduk T; Gerharz M; Bullerdiek J; Wisniewski J R
Distinct organization of DNA complexes of various HMGI/Y family proteins and their modulation upon mitotic phosphorylation.
The Journal of biological chemistry 2001;276(3):1984-92.
2001: Bol S; Belge G; Rippe V; Bullerdiek J
Molecular cytogenetic investigations define a subgroup of thyroid adenomas with 2p21 breakpoints clustered to a region of less than 450 kb.
Cytogenetics and cell genetics 2001;95(3-4):189-91.
2001: Lemke I; Rogalla P; Bullerdiek J
A novel LPP fusion gene indicates the crucial role of truncated LPP proteins in lipomas and pulmonary chondroid hamartomas.
Cytogenetics and cell genetics 2001;95(3-4):153-6.
2001: Blank C; Schoenmakers E F; Rogalla P; Huys E H; van Rijk A A; Drieschner N; Bullerdiek J
Intragenic breakpoint within RAD51L1 in a t(6;14)(p21.3;q24) of a pulmonary chondroid hamartoma.
Cytogenetics and cell genetics 2001;95(1-2):17-9.
2001: Murua Escobar H; Becker K; Bullerdiek J; Nolte I
The canine ERBB2 gene maps to a chromosome region frequently affected by aberrations in tumors of the dog (Canis familiaris).
Cytogenetics and cell genetics 2001;94(3-4):194-5.
2001: Belge G; Rippe V; Meiboom M; Drieschner N; Garcia E; Bullerdiek J
Delineation of a 150-kb breakpoint cluster in benign thyroid tumors with 19q13.4 aberrations.
Cytogenetics and cell genetics 2001;93(1-2):48-51.
2000: Rogalla P; Lemke I; Kazmierczak B; Bullerdiek J
An identical HMGIC-LPP fusion transcript is consistently expressed in pulmonary chondroid hamartomas with t(3;12)(q27-28;q14-15).
Genes, chromosomes & cancer 2000;29(4):363-6.
2000: Schwanbeck R; Gerharz M; Drung A; Rogalla P; Piekielko A; Blank C; Bullerdiek J; Wisniewski J R
Point mutations within AT-hook domains of the HMGI homologue HMGIYL1 affect binding to gene promoter but not to four-way junction DNA.
Biochemistry 2000;39(47):14419-25.
2000: Blank C; Rogalla P; Tran K H; Bullerdiek J
A novel high mobility group protein gene is a candidate for Xp22 abnormalities in uterine leiomyomas and other benign tumors.
Cancer genetics and cytogenetics 2000;121(2):172-80.
2000: Spranger S; Rommel B; Jauch A; Bodammer R; Mehl B; Bullerdiek J
Interstitial deletion of 5q33.3q35.1 in a girl with mild mental retardation.
American journal of medical genetics 2000;93(2):107-9.
2000: Santulli B; Kazmierczak B; Napolitano R; Caliendo I; Chiappetta G; Rippe V; Bullerdiek J; Fusco A
A 12q13 translocation involving the HMGI-C gene in richter transformation of a chronic lymphocytic leukemia.
Cancer genetics and cytogenetics 2000;119(1):70-3.
2000: Hennig Y; Löschke S; Katenkamp D; Bartnitzke S; Bullerdiek J
A malignant triton tumor with an unbalanced translocation (1;13)(q10;q10) and an isochromosome (8)(q10) as the sole karyotypic abnormalities.
Cancer genetics and cytogenetics 2000;118(1):80-2.
2000: Rogalla P; Kazmierczak B; Flohr A M; Hauke S; Bullerdiek J
Back to the roots of a new exon--the molecular archaeology of a SP100 splice variant.
Genomics 2000;63(1):117-22.
2000: Kazmierczak B; Dal Cin P; Rogalla P; Van den Berghe H; Bullerdiek J
Regional fine mapping of HMG17 to chromosomal band 1p35.
Cancer genetics and cytogenetics 2000;116(2):164-5.
2000: Staratschek-Jox A; Kotkowski S; Belge G; Rüdiger T; Bullerdiek J; Diehl V; Wolf J
Detection of Epstein-Barr virus in Hodgkin-Reed-Sternberg cells : no evidence for the persistence of integrated viral fragments inLatent membrane protein-1 (LMP-1)-negative classical Hodgkin's disease.
The American journal of pathology 2000;156(1):209-16.
1999: Hennig Y; Deichert U; Bonk U; Thode B; Bartnitzke S; Bullerdiek J
Chromosomal translocations affecting 12q14-15 but not deletions of the long arm of chromosome 7 associated with a growth advantage of uterine smooth muscle cells.
Molecular human reproduction 1999;5(12):1150-4.
1999: Rippe V; Belge G; Meiboom M; Kazmierczak B; Fusco A; Bullerdiek J
A KRAB zinc finger protein gene is the potential target of 19q13 translocation in benign thyroid tumors.
Genes, chromosomes & cancer 1999;26(3):229-36.
1999: Bol S; Belge G; Thode B; Bartnitzke S; Bullerdiek J
Structural abnormalities of chromosome 2 in benign thyroid tumors. Three new cases and review of the literature.
Cancer genetics and cytogenetics 1999;114(1):75-7.
1999: Bullerdiek J; Rommel B
Diagnostic and molecular implications of specific chromosomal translocations in mesenchymal tumors.
Histology and histopathology 1999;14(4):1165-73.
1999: Hörsting N; Wohlsein P; Reimann N; Bartnitzke S; Bullerdiek J; Nolte I
Cytogenetic analysis of three oropharyngeal malignant melanomas in dogs.
Research in veterinary science 1999;67(2):149-51.
1999: Kazmierczak B; Meyer-Bolte K; Tran K H; Wöckel W; Breightman I; Rosigkeit J; Bartnitzke S; Bullerdiek J
A high frequency of tumors with rearrangements of genes of the HMGI(Y) family in a series of 191 pulmonary chondroid hamartomas.
Genes, chromosomes & cancer 1999;26(2):125-33.
1999: Kazmierczak B; Dal Cin P; Sciot R; Van den Berghe H; Bullerdiek J
Inflammatory myofibroblastic tumor with HMGIC rearrangement.
Cancer genetics and cytogenetics 1999;112(2):156-60.
1999: Rohen C; Rogalla P; Meyer-Bolte K; Bartnitzke S; Chilla R; Bullerdiek J
Pleomorphic adenomas of the salivary glands: absence of HMGIY rearrangements.
Cancer genetics and cytogenetics 1999;111(2):178-81.
1999: Reimann N; Nolte I; Bonk U; Bartnitzke S; Bullerdiek J
Cytogenetic investigation of canine lipomas.
Cancer genetics and cytogenetics 1999;111(2):172-4.
1999: Kazmierczak B; Dal Cin P; Meyer-Bolte K; Van den Berghe H; Bullerdiek J
HMG1 is not rearranged by 13q12 aberrations in lipomas.
Genes, chromosomes & cancer 1999;24(3):290-2.
1999: Dal Cin P; Fusco A; Belge G; Chiappetta G; Fedele M; Pauwels P; Bullerdiek J; Van den Berghe H
Involvement of the HMGI(Y) gene in a microfollicular adenoma of the thyroid.
Genes, chromosomes & cancer 1999;24(3):286-9.
1999: Kazmierczak B; Borrmann L; Bullerdiek J
Assignment of a new gene (LBH).
Genomics 1999;56(1):136-7.
1999: Reimann N; Bartnitzke S; Nolte I; Bullerdiek J
Working with canine chromosomes: current recommendations for karyotype description.
The Journal of heredity 1999;90(1):31-4.
1999: Polito P; Dal Cin P; Kazmierczak B; Rogalla P; Bullerdiek J; Van den Berghe H
Deletion of HMG17 in uterine leiomyomas with ring chromosome 1.
Cancer genetics and cytogenetics 1999;108(2):107-9.
1999: Hennig Y; Caselitz J; Stern C; Bartnitzke S; Bullerdiek J
Karyotype evolution in a case of uterine angioleiomyoma.
Cancer genetics and cytogenetics 1999;108(1):79-80.
1998: Kazmierczak B; Dal Cin P; Wanschura S; Borrmann L; Fusco A; Van den Berghe H; Bullerdiek J
HMGIY is the target of 6p21.3 rearrangements in various benign mesenchymal tumors.
Genes, chromosomes & cancer 1998;23(4):279-85.
1998: Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
Cancer research 1998;58(21):4930-9.
1998: Rogalla P; Drechsler K; Schröder-Babo W; Eberhardt K; Bullerdiek J
HMGIC expression patterns in non-small lung cancer and surrounding tissue.
Anticancer research 1998;18(5A):3327-30.
1998: Hörsting N; von Reiswitz A; Wohlsein P; Bullerdiek J; Reimann N; Nolte I
[Oropharyngeal tumors of dogs--a clinical study of 79 cases]
Berliner und Münchener tierärztliche Wochenschrift 1998;111(7-8):242-7.
1998: Dal Cin P; Timmerman D; Van den Berghe I; Wanschura S; Kazmierczak B; Vergote I; Deprest J; Neven P; Moerman P; Bullerdiek J; Van den Berghe H
Genomic changes in endometrial polyps associated with tamoxifen show no evidence for its action as an external carcinogen.
Cancer research 1998;58(11):2278-81.
1998: Kazmierczak B; Bullerdiek J; Pham K H; Bartnitzke S; Wiesner H
Intron 3 of HMGIC is the most frequent target of chromosomal aberrations in human tumors and has been conserved basically for at least 30 million years.
Cancer genetics and cytogenetics 1998;103(2):175-7.
1998: Staats B; Bonk U; Gohla G; Bartnitzke S; Bullerdiek J
Two cases of fibrocystic breast disease with polysomy 18 as the sole clonal cytogenetic abnormality.
Cancer genetics and cytogenetics 1998;103(2):91-4.
1998: Rogalla P; Kazmierczak B; Meyer-Bolte K; Tran K H; Bullerdiek J
The t(3;12)(q27;q14-q15) with underlying HMGIC-LPP fusion is not determining an adipocytic phenotype.
Genes, chromosomes & cancer 1998;22(2):100-4.
1998: Dal Cin P; Wanschura S; Kazmierczak B; Tallini G; Dei Tos A; Bullerdiek J; Van den Berghe I; Moerman P; Van den Berghe H
Amplification and expression of the HMGIC gene in a benign endometrial polyp.
Genes, chromosomes & cancer 1998;22(2):95-9.
1998: Roque L; Clode A; Belge G; Pinto A; Bartnitzke S; Santos J R; Thode B; Bullerdiek J; Castedo S; Soares J
Follicular thyroid carcinoma: chromosome analysis of 19 cases.
Genes, chromosomes & cancer 1998;21(3):250-5.
1998: Kazmierczak B; Dal Cin P; Wanschura S; Bartnitzke S; Van den Berghe H; Bullerdiek J
Cloning and molecular characterization of part of a new gene fused to HMGIC in mesenchymal tumors.
The American journal of pathology 1998;152(2):431-5.
1998: Reimann N; Bartnitzke S; Bullerdiek J; Mischke R; Nolte I
Trisomy 1 in a canine acute leukemia indicating the pathogenetic importance of polysomy 1 in leukemias of the dog.
Cancer genetics and cytogenetics 1998;101(1):49-52.
1998: Belge G; Roque L; Soares J; Bruckmann S; Thode B; Fonseca E; Clode A; Bartnitzke S; Castedo S; Bullerdiek J
Cytogenetic investigations of 340 thyroid hyperplasias and adenomas revealing correlations between cytogenetic findings and histology.
Cancer genetics and cytogenetics 1998;101(1):42-8.
1998: Rogalla P; Borda Z; Meyer-Bolte K; Tran K H; Hauke S; Nimzyk R; Bullerdiek J
Mapping and molecular characterization of five HMG1-related DNA sequences.
Cytogenetics and cell genetics 1998;83(1-2):124-9.
1997: Belge G; Garcia E; Rippe V; Fusco A; Bartnitzke S; Bullerdiek J
Breakpoints of 19q13 translocations of benign thyroid tumors map within a 400 kilobase region.
Genes, chromosomes & cancer 1997;20(2):201-3.
1997: Hennig Y; Caselitz J; Bartnitzke S; Bullerdiek J
A third case of a low-grade endometrial stromal sarcoma with a t(7;17)(p14 approximately 21;q11.2 approximately 21).
Cancer genetics and cytogenetics 1997;98(1):84-6.
1997: Dal Cin P; Wanschura S; Christiaens M R; Van den Berghe I; Moerman P; Polito P; Kazmierczak B; Bullerdiek J; Van den Berghe H
Hamartoma of the breast with involvement of 6p21 and rearrangement of HMGIY.
Genes, chromosomes & cancer 1997;20(1):90-2.
1997: Rommel B; Rogalla P; Jox A; Kalle C V; Kazmierczak B; Wolf J; Bullerdiek J
HMGI-C, a member of the high mobility group family of proteins, is expressed in hematopoietic stem cells and in leukemic cells.
Leukemia & lymphoma 1997;26(5-6):603-7.
1997: Nolte I; Reimann N; Bullerdiek J; Bartnitzke S; Mischke R; Nolte M
[Importance of cytogenetic investigations in canine leukemias]
Tierärztliche Praxis 1997;25(4):393-7.
1997: Rogalla P; Drechsler K; Kazmierczak B; Rippe V; Bonk U; Bullerdiek J
Expression of HMGI-C, a member of the high mobility group protein family, in a subset of breast cancers: relationship to histologic grade.
Molecular carcinogenesis 1997;19(3):153-6.
1997: Hennig Y; Rogalla P; Wanschura S; Frey G; Deichert U; Bartnitzke S; Bullerdiek J
HMGIC expressed in a uterine leiomyoma with a deletion of the long arm of chromosome 7 along with a 12q14-15 rearrangement but not in tumors showing del(7) as the sole cytogenetic abnormality.
Cancer genetics and cytogenetics 1997;96(2):129-33.
1997: Wanschura S; Dal Cin P; Kazmierczak B; Bartnitzke S; Van den Berghe H; Bullerdiek J
Hidden paracentric inversions of chromosome arm 12q affecting the HMGIC gene.
Genes, chromosomes & cancer 1997;18(4):322-3.
1997: Belge G; Caselitz J; Bonk U; Bartnitzke S; Bullerdiek J
[Genetic studies of differential fatty tissue tumor diagnosis]
Der Pathologe 1997;18(2):160-6.
1997: Belge G; Roque L; Thode B; Fonseca E; Soares J; Clode A; Bartnitzke S; Castedo S; Bullerdiek J
[Cytogenetic changes in benign thyroid gland hyperplasias and adenomas correlated with histology]
Verhandlungen der Deutschen Gesellschaft für Pathologie 1997;81():151-6.
1997: Jox A; Rohen C; Belge G; Bartnitzke S; Pawlita M; Diehl V; Bullerdiek J; Wolf J
Integration of Epstein-Barr virus in Burkitt's lymphoma cells leads to a region of enhanced chromosome instability.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8 Suppl 2():131-5.
1996: Kazmierczak B; Pohnke Y; Bullerdiek J
Fusion transcripts between the HMGIC gene and RTVL-H-related sequences in mesenchymal tumors without cytogenetic aberrations.
Genomics 1996;38(2):223-6.
1996: Kazmierczak B; Bol S; Wanschura S; Bartnitzke S; Bullerdiek J
PAC clone containing the HMGI(Y) gene spans the breakpoint of a 6p21 translocation in a uterine leiomyoma cell line.
Genes, chromosomes & cancer 1996;17(3):191-3.
1996: Röijer E; Kas K; Klawitz I; Bullerdiek J; Van de Ven W; Stenman G
Identification of a yeast artificial chromosome spanning the 8q12 translocation breakpoint in pleomorphic adenomas with t(3;8)(p21;q12).
Genes, chromosomes & cancer 1996;17(3):166-71.
1996: Rogalla P; Rohen C; Bonk U; Bullerdiek J
Telomeric repeat fragment lengths are not correlated to histological grading in 85 breast cancers.
Cancer letters 1996;106(2):155-61.
1996: Reimann N; Nolte I; Bonk U; Werner M; Bullerdiek J; Bartnitzke S
Trisomy 18 in a canine thyroid adenoma.
Cancer genetics and cytogenetics 1996;90(2):154-6.
1996: Kazmierczak B; Wanschura S; Rommel B; Bartnitzke S; Bullerdiek J
Ten pulmonary chondroid hamartomas with chromosome 6p21 breakpoints within the HMG-I(Y) gene or its immediate surroundings.
Journal of the National Cancer Institute 1996;88(17):1234-6.
1996: Rogalla P; Drechsler K; Frey G; Hennig Y; Helmke B; Bonk U; Bullerdiek J
HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors.
The American journal of pathology 1996;149(3):775-9.
1996: Bol S; Wanschura S; Thode B; Deichert U; Van de Ven W J; Bartnitzke S; Bullerdiek J
An endometrial polyp with a rearrangement of HMGI-C underlying a complex cytogenetic rearrangement involving chromosomes 2 and 12.
Cancer genetics and cytogenetics 1996;90(1):88-90.
1996: Belge G; Bruckmann S; Thode B; Bartnitzke S; Bullerdiek J
Deletions of the short arm of chromosome 2 characterize a new cytogenetic subgroup of benign thyroid tumors.
Genes, chromosomes & cancer 1996;16(2):149-51.
1996: Hennig Y; Wanschura S; Deichert U; Bartnitzke S; Bullerdiek J
Rearrangements of the high mobility group protein family genes and the molecular genetic origin of uterine leiomyomas and endometrial polyps.
Molecular human reproduction 1996;2(4):277-83.
1996: Rohen C; Staats B; Bonk U; Bartnitzke S; Bullerdiek J
Significance of clonal chromosome aberrations in breast fibroadenomas.
Cancer genetics and cytogenetics 1996;87(2):152-5.
1996: Hennig Y; Deichert U; Stern C; Ghassemi A; Thode B; Bonk U; Meister P; Bartnitzke S; Bullerdiek J
Structural aberrations of chromosome 6 in three uterine smooth muscle tumors.
Cancer genetics and cytogenetics 1996;87(2):148-51.
1996: Wanschura S; Kazmierczak B; Pohnke Y; Meyer-Bolte K; Bartnitzke S; Van de Ven W J; Bullerdiek J
Transcriptional activation of HMGI-C in three pulmonary hamartomas each with a der(14)t(12;14) as the sole cytogenetic abnormality.
Cancer letters 1996;102(1-2):17-21.
1996: Wanschura S; Schoenmakers E F; Huysmans C; Bartnitzke S; Van de Ven W J; Bullerdiek J
Mapping of the gene encoding the human hepatoma-derived growth factor (HDGF) with homology to the high-mobility group (HMG)-1 protein to Xq25.
Genomics 1996;32(2):298-300.
1996: Leuschner E; Staats B; Gohla G; Bartnitzke S; Bonk U; Bullerdiek J
Fluorescence in situ hybridization studies on breast tumor samples for distinguishing between different subsets of breast cancer.
Acta cytologica 1996;40(2):151-7.
1996: Kazmierczak B; Rosigkeit J; Wanschura S; Meyer-Bolte K; Van de Ven W J; Kayser K; Krieghoff B; Kastendiek H; Bartnitzke S; Bullerdiek J
HMGI-C rearrangements as the molecular basis for the majority of pulmonary chondroid hamartomas: a survey of 30 tumors.
Oncogene 1996;12(3):515-21.
1996: Wanschura S; Belge G; Stenman G; Kools P; Dal Cin P; Schoenmakers E; Huysmans C; Van den Berghe H; Bartnitzke S; Van de Ven W J; Bullerdiek J
Mapping of the translocation breakpoints of primary pleomorphic adenomas and lipomas within a common region of chromosome 12.
Cancer genetics and cytogenetics 1996;86(1):39-45.
1996: Staats B; Bonk U; Wanschura S; Hanisch P; Schoenmakers E F; Van de Ven W J; Bartnitzke S; Bullerdiek J
A fibroadenoma with a t(4;12) (q27;q15) affecting the HMGI-C gene, a member of the high mobility group protein gene family.
Breast cancer research and treatment 1996;38(3):299-303.
1996: Reimann N; Bartnitzke S; Bullerdiek J; Schmitz U; Rogalla P; Nolte I; Rønne M
An extended nomenclature of the canine karyotype.
Cytogenetics and cell genetics 1996;73(1-2):140-4.
1995: Kazmierczak B; Hennig Y; Wanschura S; Rogalla P; Bartnitzke S; Van de Ven W; Bullerdiek J
Description of a novel fusion transcript between HMGI-C, a gene encoding for a member of the high mobility group proteins, and the mitochondrial aldehyde dehydrogenase gene.
Cancer research 1995;55(24):6038-9.
1995: Schoenmakers E F; Geurts J M; Kools P F; Mols R; Huysmans C; Bullerdiek J; Van den Berghe H; Van de Ven W J
A 6-Mb yeast artificial chromosome contig and long-range physical map encompassing the region on chromosome 12q15 frequently rearranged in a variety of benign solid tumors.
Genomics 1995;29(3):665-78.
1995: Rohen C; Caselitz J; Stern C; Wanschura S; Schoenmakers E F; Van de Ven W J; Bartnitzke S; Bullerdiek J
A hamartoma of the breast with an aberration of 12q mapped to the MAR region by fluorescence in situ hybridization.
Cancer genetics and cytogenetics 1995;84(1):82-4.
1995: Wanschura S; Kazmierczak B; Schoenmakers E; Meyen E; Bartnitzke S; Van de Ven W; Bullerdiek J; Schloot W
Regional fine mapping of the multiple-aberration region involved in uterine leiomyoma, lipoma, and pleomorphic adenoma of the salivary gland to 12q15.
Genes, chromosomes & cancer 1995;14(1):68-70.
1995: Kazmierczak B; Wanschura S; Meyer-Bolte K; Caselitz J; Meister P; Bartnitzke S; Van de Ven W; Bullerdiek J
Cytogenic and molecular analysis of an aggressive angiomyxoma.
The American journal of pathology 1995;147(3):580-5.
1995: Wolf J; Jox A; Skarbek H; Pukrop T; Bartnitzke S; Pawlita M; Diehl V; Bullerdiek J
Selective loss of integrated Epstein-Barr virus genomes after long-term cultivation of Burkitt's lymphoma x B-lymphoblastoid cell hybrids due to chromatin instability at the integration site.
Virology 1995;212(1):179-85.
1995: Schoenmakers E F; Wanschura S; Mols R; Bullerdiek J; Van den Berghe H; Van de Ven W J
Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours.
Nature genetics 1995;10(4):436-44.
1995: Kazmierczak B; Wanschura S; Rosigkeit J; Meyer-Bolte K; Uschinsky K; Haupt R; Schoenmakers E F; Bartnitzke S; Van de Ven W J; Bullerdiek J
Molecular characterization of 12q14-15 rearrangements in three pulmonary chondroid hamartomas.
Cancer research 1995;55(12):2497-9.
1995: Rogalla P; Rohen C; Hennig Y; Deichert U; Bonk U; Bullerdiek J
Telomere repeat fragment sizes do not limit the growth potential of uterine leiomyomas.
Biochemical and biophysical research communications 1995;211(1):175-82.
1995: Kazmierczak B; Stern C; Bartnitzke S; Bullerdiek J
Non-random jumping translocations as a result of SV40 large T-antigen expression in benign human tumor cells.
Cell biology international 1995;19(4):315-22.
1995: Van de Ven W J; Schoenmakers E F; Wanschura S; Kazmierczak B; Kools P F; Geurts J M; Bartnitzke S; Van den Berghe H; Bullerdiek J
Molecular characterization of MAR, a multiple aberration region on human chromosome segment 12q13-q15 implicated in various solid tumors.
Genes, chromosomes & cancer 1995;12(4):296-303.
1995: Rohen C; Meyer-Bolte K; Bonk U; Ebel T; Staats B; Leuschner E; Gohla G; Caselitz J; Bartnitzke S; Bullerdiek J
Trisomy 8 and 18 as frequent clonal and single-cell aberrations in 185 primary breast carcinomas.
Cancer genetics and cytogenetics 1995;80(1):33-9.
1995: Kools P F; Wanschura S; Schoenmakers E F; Geurts J M; Mols R; Kazmierczak B; Bullerdiek J; Van den Berghe H; Van de Ven W J
Identification of the chromosome 12 translocation breakpoint region of a pleomorphic salivary gland adenoma with t(1;12)(p22;q15) as the sole cytogenetic abnormality.
Cancer genetics and cytogenetics 1995;79(1):1-7.
1995: Belge G; Garcia E; de Jong P; Bartnitzke S; Bullerdiek J
FISH analyses of a newly established thyroid tumor cell line showing a t(1;19)(p35 or p36.1;q13) reveal that the breakpoint lies between 19q13.3-13.4 and 19q13.4.
Cytogenetics and cell genetics 1995;69(3-4):220-2.
1995: Wanschura S; Hennig Y; Deichert U; Schoenmakers E F; Van de Ven W J; Bartnitzke S; Bullerdiek J
Molecular-cytogenetic refinement of the 12q14-->q15 breakpoint region affected in uterine leiomyomas.
Cytogenetics and cell genetics 1995;71(2):131-5.
1994: Belge G; Thode B; Bartnitzke S; Bullerdiek J
Cytogenetic biclonality corresponding to multiphasic differentiation in an atypical thyroid adenoma.
Cancer genetics and cytogenetics 1994;78(1):102-4.
1994: Rogalla P; Kazmierczak B; Rohen C; Trams G; Bartnitzke S; Bullerdiek J
Two human breast cancer cell lines showing decreasing telomeric repeat length during early in vitro passaging.
Cancer genetics and cytogenetics 1994;77(1):19-25.
1994: Schoenmakers E F; Mols R; Wanschura S; Kools P F; Geurts J M; Bartnitzke S; Bullerdiek J; van den Berghe H; Van de Ven W J
Identification, molecular cloning, and characterization of the chromosome 12 breakpoint cluster region of uterine leiomyomas.
Genes, chromosomes & cancer 1994;11(2):106-18.
1994: Leuschner E; Meyer-Bolte K; Caselitz J; Bartnitzke S; Bullerdiek J
Fibroadenoma of the breast showing a translocation (6;14), a ring chromosome and two markers involving parts of chromosome 11.
Cancer genetics and cytogenetics 1994;76(2):145-7.
1994: Belge G; Thode B; Rippe V; Bartnitzke S; Bullerdiek J
A characteristic sequence of trisomies starting with trisomy 7 in benign thyroid tumors.
Human genetics 1994;94(2):198-202.
1994: Bullerdiek J; Bonk U; Staats B; Leuschner E; Gohla G; Ebel T; Bartnitzke S
Trisomy 18 as the first chromosome abnormality in a medullary breast cancer.
Cancer genetics and cytogenetics 1994;73(1):75-8.
1994: Schoenmakers E F; Kools P F; Mols R; Kazmierczak B; Bartnitzke S; Bullerdiek J; Dal Cin P; De Jong P J; Van den Berghe H; Van de Ven W J
Physical mapping of chromosome 12q breakpoints in lipoma, pleomorphic salivary gland adenoma, uterine leiomyoma, and myxoid liposarcoma.
Genomics 1994;20(2):210-22.
1994: Franke S; Klawitz I; Schnakenberg E; Rommel B; Van de Ven W; Bullerdiek J; Schloot W
Isolation and mapping of a cosmid clone containing the human NAT2 gene.
Biochemical and biophysical research communications 1994;199(1):52-5.
1994: Kools P F; Roebroek A J; Van de Velde H J; Marynen P; Bullerdiek J; Van de Ven W J
Regional mapping of the human NSP gene to chromosome region 14q21-->q22 by fluorescence in situ hybridization analysis.
Cytogenetics and cell genetics 1994;66(1):48-50.
1994: Reimann N; Rogalla P; Kazmierczak B; Bonk U; Nolte I; Grzonka T; Bartnitzke S; Bullerdiek J
Evidence that metacentric and submetacentric chromosomes in canine tumors can result from telomeric fusions.
Cytogenetics and cell genetics 1994;67(2):81-5.
1994: Kapp U; Düx A; Schell-Frederick E; Banik N; Hummel M; Mücke S; Fonatsch C; Bullerdiek J; Gottstein C; Engert A
Disseminated growth of Hodgkin's-derived cell lines L540 and L540cy in immune-deficient SCID mice.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 1():121-6.
1993: Rohen C; Bonk U; Staats B; Bartnitzke S; Bullerdiek J
Two human breast tumors with translocations involving 12q13-15 as the sole cytogenetic abnormality.
Cancer genetics and cytogenetics 1993;69(1):68-71.
1993: Wolf J; Pawlita M; Jox A; Kohls S; Bartnitzke S; Diehl V; Bullerdiek J
Integration of Epstein Barr virus near the breakpoint of a translocation 11;19 in a Burkitt's lymphoma cell line.
Cancer genetics and cytogenetics 1993;67(2):90-4.
1993: Bullerdiek J; Leuschner E; Taquia E; Bonk U; Bartnitzke S
Trisomy 8 as a recurrent clonal abnormality in breast cancer?
Cancer genetics and cytogenetics 1993;65(1):64-7.
1993: Bullerdiek J; Wobst G; Meyer-Bolte K; Chilla R; Haubrich J; Thode B; Bartnitzke S
Cytogenetic subtyping of 220 salivary gland pleomorphic adenomas: correlation to occurrence, histological subtype, and in vitro cellular behavior.
Cancer genetics and cytogenetics 1993;65(1):27-31.
1993: Schoenmakers H F; Kools P F; Kazmierczak B; Bullerdiek J; Claussen U; Horsthemke B; Van den Berghe H; Van de Ven W J
Isolation of a somatic cell hybrid retaining the der(16)t(12;16)(q13;p11.2) from a myxoid liposarcoma cell line.
Cytogenetics and cell genetics 1993;62(2-3):159-61.
1992: Stern C; Deichert U; Thode B; Bartnitzke S; Bullerdiek J
[Cytogenetic subtyping of 139 uterine leiomyoma]
Geburtshilfe und Frauenheilkunde 1992;52(12):767-72.
1992: Bartnitzke S; Motzko H; Rosenhagen C; Bullerdiek J
Benign mixed tumor of canine mammary gland showing an r(X) and trisomy 5 as the only clonal abnormalities.
Cancer genetics and cytogenetics 1992;62(1):29-31.
1992: Kazmierczak B; Thode B; Bartnitzke S; Bullerdiek J; Schloot W
Pleomorphic adenoma cells vary in their susceptibility to SV40 transformation depending on the initial karyotype.
Genes, chromosomes & cancer 1992;5(1):35-9.
1992: Belge G; Thode B; Bullerdiek J; Bartnitzke S
Aberrations of chromosome 19. Do they characterize a subtype of benign thyroid adenomas?
Cancer genetics and cytogenetics 1992;60(1):23-6.
1992: Belge G; Kazmierczak B; Meyer-Bolte K; Bartnitzke S; Bullerdiek J
Expression of SV40 T-antigen in lipoma cells with a chromosomal translocation T(3;12) is not sufficient for direct immortalization.
Cell biology international reports 1992;16(4):339-47.
1992: Bartnitzke S; Motzko H; Caselitz J; Kornberg M; Bullerdiek J; Schloot W
A recurrent marker chromosome involving chromosome 1 in two mammary tumors of the dog.
Cytogenetics and cell genetics 1992;60(2):135-7.
1991: Belge G; Thode B; Bullerdiek J; Bartnitzke S
Deletion of part of the long arm of chromosome 13 as the only karyotypic aberration in a follicular thyroid adenoma.
Cancer genetics and cytogenetics 1991;56(2):277-80.
1991: Stern C; Kazmierczak B; Thode B; Rommel B; Bartnitzke S; Dal Cin P; van de Ven W; Van den Berghe H; Bullerdiek J
Leiomyoma cells with 12q15 aberrations can be transformed in vitro and show a relatively stable karyotype during precrisis period.
Cancer genetics and cytogenetics 1991;54(2):223-8.
1991: Rommel B; de Villiers E M; Dürst M; Bartnitzke S; Bullerdiek J
Failure to detect human papillomavirus sequences at the 3p21 rearrangement site in pleomorphic adenomas.
Cancer genetics and cytogenetics 1991;52(2):187-91.
1990: Bullerdiek J; Vollrath M; Wittekind C; Caselitz J; Bartnitzke S
Mucoepidermoid tumor of the parotid gland showing a translocation (3;8)(p21;q12) and a deletion (5)(q22) as sole chromosome abnormalities.
Cancer genetics and cytogenetics 1990;50(1):161-4.
1990: Rommel B; Bullerdiek J; Bartnitzke S; Schloot W
No rearrangement of c-mos in salivary gland pleomorphic adenomas with 8q12 aberrations.
Cancer genetics and cytogenetics 1990;49(2):165-9.
1990: Stern C; Meyer K; Bartnitzke S; Schloot W; Bullerdiek J
Pleomorphic adenomas with unbalanced chromosomal abnormalities have an increased in vitro lifetime.
Cancer genetics and cytogenetics 1990;46(1):55-63.
1990: Bullerdiek J; Hutter K J; Brandt G; Weinberg M; Belge G; Bartnitzke S
Cytogenetic investigations on a cell line derived from a carcinoma arising in a salivary gland pleomorphic adenoma.
Cancer genetics and cytogenetics 1990;44(2):253-62.
1990: Bartnitzke S; Eberhardt D; Krooss J; Rommel B; Bullerdiek J
In situ nick translation of human chromosomes using Alu I: unmasking of recognition sites by proteinase K pretreatment.
Cytobios 1990;62(249):93-9.
1990: Kazmierczak B; Bartnitzke S; Hartl M; Bullerdiek J
In vitro transformation by the SV40 'early region' of cells from a human benign salivary gland tumor with a 12q13----q15 rearrangement.
Cytogenetics and cell genetics 1990;53(1):37-9.
1989: Bullerdiek J; Takla G; Bartnitzke S; Brandt G; Chilla R; Haubrich J
Relationship of cytogenetic subtypes of salivary gland pleomorphic adenomas with patient age and histologic type.
Cancer 1989;64(4):876-80.
1989: Bartnitzke S; Herrmann M E; Lobeck H; Zuschneid W; Neuhaus P; Bullerdiek J
Cytogenetic findings on eight follicular thyroid adenomas including one with a t(10;19).
Cancer genetics and cytogenetics 1989;39(1):65-8.
1988: Bullerdiek J; Haubrich J; Meyer K; Bartnitzke S
Translocation t(11;19)(q21;p13.1) as the sole chromosome abnormality in a cystadenolymphoma (Warthin's tumor) of the parotid gland.
Cancer genetics and cytogenetics 1988;35(1):129-32.
1988: Rommel B; Hutter K J; Bullerdiek J; Bartnitzke S; Goerttler K; Schloot W
Identification of flow-sorted chromosomes by G-banding and in situ hybridization.
Cytometry 1988;9(5):504-7.
1988: Bullerdiek J; Chilla R; Haubrich J; Meyer K; Bartnitzke S
A causal relationship between chromosomal rearrangements and the genesis of salivary gland pleomorphic adenomas.
Archives of oto-rhino-laryngology 1988;245(4):244-9.
1987: Bullerdiek J; Raabe G; Böschen C; Bartnitzke S
Translocation (3;8;8)(p22 or p23;p23;q12) in a case of pleomorphic adenoma: similarity to a primary cytogenetic abnormality detected in an endometrial adenocarcinoma.
Cancer genetics and cytogenetics 1987;27(1):177-80.
1987: Bullerdiek J; Raabe G; Bartnitzke S; Böschen C; Schloot W
Structural rearrangements of chromosome Nr 8 involving 8q12--a primary event in pleomorphic ademona of the parotid gland.
Genetica 1987;72(2):85-92.
1987: Bullerdiek J; Böschen C; Bartnitzke S
Aberrations of chromosome 8 in mixed salivary gland tumors--cytogenetic findings on seven cases.
Cancer genetics and cytogenetics 1987;24(2):205-12.
1987: Bullerdiek J; Bartnitzke S; Weinberg M; Chilla R; Haubrich J; Schloot W
Rearrangements of chromosome region 12q13----q15 in pleomorphic adenomas of the human salivary gland (PSA).
Cytogenetics and cell genetics 1987;45(3-4):187-90.

Sign-in to see more